L'ANRS à la 5ème Conférence de l'IAS (19-22 juillet, Cape Town, Afrique du Sud)
L'ANRS organise :
In the context of extensive HIV testing, should HIV therapy be started earlier?
- The WHO guidelines and their implications, Pedro Cahn, Director of Huesped Foundation, Argentina
- Morbidity and mortality before and after treatment initiation : looking for the best CD4 threshold to start ART in subsaharan Africa, Raoul Moh, PACCI-ANRS Program, Côte d’Ivoire
- Psychosocial issues for non ART eligible patients, Bruno Spire, Inserm-IRD Research Unit, President of AIDES, France
Round table: Marco Vitoria, Department of HIV/AIDS, WHO, Switzerland, Susan Cleary, Health Economics Unit, University of Cape Town, South Africa
Is the virological monitoring an appropriate and feasible tool for follow upof treated patients?
Chairs: Avelin F. Aghokeng, Unit Resarch IRD/IMPM, Cameroon, James McIntyre, Perinatal HIV Research Unit, University of the Witwatersrand, South Africa
- Implementation of Real Time PCR in low and middle income countries, Christine Rouzioux, University Paris Descartes, Necker Hospital, France
- The use of viral load monitoring in the South African national program, Andrew Boulle , School of Public Health and Family Medicine, University of Cape Town, South Africa
An economical assessment of the HIV monitoring assays market in developing countries.
The Brazilian experience, Cristina d’Almeida, University Paris XIII, France
Round table: Trevor F. Peter and Maurine M. Murtagh, Clinton Foundation HIV/AIDS Initiative, USA, James McIntyre, UNITAID, Switzerland
Conclusion: Patrice Debré, Ambassador in charge of the fight against AIDS and communicable diseases, France
Scientific committee: Brigitte Bazin, Eric Delaporte, Véronique Doré, Jean-Paul Moatti, Christine Rouzioux, Marie-Christine Simon, Bruno Spire
A lire les communiqués de presse